HCV incidence in people with HIV in southwest China: A retrospective cohort study (2004–2023)
HIV Medicine · 2025
DOI: 10.1111/hiv.70033 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift HIV Medicine, 2025. Verfasst von Minyang Xiao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Center for Disease Control and Prevention, Kunming, China. Hauptthemen laut MEDLINE: HIV Infections, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Science and Technology Major Project of China.
Abstract (Originalsprache)
Introduction
Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections are global public health concerns. Little research has been conducted on HCV incidence in people with HIV (PWH).
Methods
This was a retrospective cohort study to investigate HCV incidence and associated factors in PWH. HCV‐negative PWH registered in national HIV databases were enrolled and followed up from 2004 to 2023. Cox proportional hazards models were utilized to identify factors associated with HCV infections.
Results
The study followed 50 245 HCV‐negative PWH, totaling 272 979.3 person‐years (PYs) of observation. We noted an HCV incidence rate of 0.70 per 100 PYs (95% confidence interval (CI) 0.67–0.73). Multivariate analysis indicated that being female (adjusted hazard ratio [aHR] 0.70), married (aHR 0.88), and those involved in homosexual intercourse (aHR 0.57) were associated with a lower risk of HCV infection. Conversely, an increased risk was found among those aged 20–39 years (aHR 2.97), 40–59 years (aHR 3.11), ≥ 60 years (aHR 1.80), treated at county‐level antiretroviral therapy (ART) clinics (aHR 1.19), township‐level ART clinics (aHR 1.83), those with a history of intravenous drug use (aHR 21.72), and individuals without CD4 testing (aHR 66.05) or HIV viral load testing (aHR 2.09). A 36% relative reduction in HCV transmission (aHR 0.64) was observed from 2010 to 2015, and a 29% relative reduction (aHR 0.71) was noted after 2016 compared with the pre‐2010 levels.
Conclusions
Despite the decrease in HCV incidence after 2010, achieving HCV elimination in PWH remains challenging. Future endeavours should prioritize improving HCV testing, intervention, and treatment in PWH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yunnan Center for Disease Control and Prevention, Kunming, China.
- Yunnan Key Laboratory of Cross-Border Infectious Disease Prevention and New Drug Development, Kunming, China.
- Yunnan Provincial Hospital of Infectious Disease, AIDS Care Center (YNACC), Kunming, China.
- Yunnan Provincial Key Laboratory of Public Health and Biosafety & School of Public Health, Kunming Medical University, Kunming, China.
- National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
ORCID-Profile: Minyang Xiao
Förderung
- National Science and Technology Major Project of China
Zitieren
APA
Xiao, M., Shi, Y., Lao, Y., Ma, Y., Lou, J., Zhang, Z., Fu, L., Han, Y., Huo, J., Zhang, X., Guo, Y., Jia, M., & Li, J. (2025). HCV incidence in people with HIV in southwest China: A retrospective cohort study (2004–2023). HIV Medicine. https://doi.org/10.1111/hiv.70033
Vancouver
Xiao M, Shi Y, Lao Y, Ma Y, Lou J, Zhang Z, et al. HCV incidence in people with HIV in southwest China: A retrospective cohort study (2004–2023). HIV Medicine. 2025. doi:10.1111/hiv.70033
BibTeX
@article{Xiao2025,
author = {Xiao, Minyang and Shi, Yuhua and Lao, Yunfei and Ma, Yanling and Lou, Jincheng and Zhang, Zuyang and Fu, Liru and Han, Yu and Huo, Junli and Zhang, Xiaobin and Guo, Yan and Jia, Manhong and Li, Jian},
title = {HCV incidence in people with HIV in southwest China: A retrospective cohort study (2004–2023)},
journal = {HIV Medicine},
year = {2025},
doi = {10.1111/hiv.70033}
}
EUVIMED